Subcutaneous anifrolumab (Saphnelo) added to standard therapy significantly improves treatment outcomes in patients with systemic lupus erythematosus (SLE). In the phase 3 TULIP-SC trial, anifrolumab met its primary BICLA endpoint…
Getting a full night of sleep may play a larger role in longevity than many people realize. New research from Oregon Health & Science University indicates that regularly getting too…
USA: A new study, published in Ophthalmology, has revealed that the Pooled Cohort Equations cardiovascular risk score—which integrates age, sex, blood pressure, cholesterol levels, and smoking status to estimate 10-year…
The FDA has approved ProlivRx, the first prescription, home-based brain neuromodulation therapy, as an adjunctive treatment for adults whose depression has not responded adequately to antidepressants. Developed by Neurolief, the…
China: A large real-world study from Hong Kong suggests that rosuvastatin and atorvastatin have comparable effects on progression to end-stage kidney disease (ESKD) in Chinese patients with diabetes. While rosuvastatin…
Child and neonatal health remains a significant global and national priority, serving as a crucial indicator of a nation's well-being and developmental progress. Annually, millions of infants worldwide are affected…
USA: Researchers have reported that low vitamin D levels are strongly linked to a higher risk of death and cardiovascular complications in patients with systemic lupus erythematosus (SLE), highlighting a…
The FDA delayed reviews of two drugs chosen for the Trump administration's new fast-track program after agency scientists flagged safety and efficacy concerns
Here are the top health stories for the day:NEET PG 2025 Cut-Off Fixed at -40: Doctors Warn of Merit DilutionDoctors have expressed their concerns over the recent decision of the…
New Delhi: The national capital has seen a rising trend in attacks on doctors and medical staff over the past five years, with a total of 149 incidents of violence…